---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-042937"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T00:39:29.961504+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx Q1 revenue +51% to $19.7M; Adj EBITDA improves to $(0.3)M; reaffirms FY guidance

## Summary
- Revenue $19.7M, +51% YoY; gross profit $12.2M, +64% YoY.
- GAAP net loss $(6.9)M ($0.38/share); Non-GAAP net loss $(2.0)M ($0.11/share).
- Adjusted EBITDA improved to $(0.3)M from $(2.2)M a year ago.
- Won 9 DAAP (AI-platform) deals in Q1; Net Revenue Retention 116% vs 86%.
- Reiterated FY2024 guidance: revenue at least $100M, Adj EBITDA at least $11M.

## SEC filing metadata
- accession: 0001213900-24-042937
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390024042937/0001213900-24-042937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390024042937/ea0206046-8k_optimize.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-042937
- JSON: https://secwatch.observer/filing/0001213900-24-042937.json
- Plain text: https://secwatch.observer/filing/0001213900-24-042937.txt

## Key facts
- Earnings Releases
  OptimizeRx Corp reported financial results for the first quarter ended March 31, 2024.
  - Period: the first quarter ended March 31, 2024
  - Result: reported results
  source text: On May 14, 2024, OptimizeRx Corporation issued a press release announcing its financial results for the first quarter ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000121390024042937/0001213900-24-042937-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.